|

AK146D1 for injection Clinical Trials

3 actively recruiting trials

▲ +1 trial since June 2026

Pipeline

Phase 1: 2Phase 2: 1

Top Sponsors

  • Akeso3

Indications

  • Cancer3
  • Advanced Solid Tumors2
  • Advanced Non Small Cell Lung Cancer (NSCLC)1
  • Lung Cancer1

Other3 trials

A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer
Phase 2
A Study of AK146D1 for Injection in Advanced Solid Tumors
Phase 1
A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.